Chrai Associates
Services
Publications
Links
Contact Us
Contact Us
   
 
 
LIST OF PATENTS
1. Polyvinyl Alcohol Ophthalmic Gel Issued 3/10/81 Patent   US No.  4255415
2. Apparatus and Methods for Dry Powder Inhaler Pending US File No. 12434P
3. Stable Injectable Antibiotic Mixture 1979 INT. File No.  2128
4. Color-Stablized Injectable Antibiotic Formulations 1976 US. File No.  2121
5. Pharmaceutical Product and Method of Making Pending US File No.  176650-8
6. Pharmaceutical Product and Method of Making
And Apparatus for Making Same		 Published PCT WO File No. 176650-8 PCT
7. Liquid Pharmaceutical for Oral Delivery Pending US File No. 176650-9
8. Dry Powder Dispensing Device Issued 6/4/02 Patent No. US 6397840
9. Method of Dispensing Dry Powder and
Dispensing Device		 Pending WO File No.176650-84PCT
10. Multi-Step Drug Dosage Forms Issued 3/9/04 Patent   No.  US 6702803
11. Method for Formulating Healthcare Products
with Enhanced  Stability		 Issued 1/17/02 Patent No. WO 02/03965 A1
12. Improved Solid Pharmaceutical Dosage
Formulation of Hydrophobic Drugs		 Issued 2/21/02 Patent No. WO 02/13762 A2
13. Substrates for Powder Deposition
Containing Conductive Domains		 Issued 1/17/02 Patent No. WO 02/04202 A1
14. Medication Dispenser for Flat Dosage Forms Issued 1/3/02 Patent No. WO 02/01518 A1
15. Medication Dispenser for Dispensing
Flat Dosage Forms		 Issued 3/4/03 Patent No. US 6527138 B2
16. Device for Delivering Charged Powder for
Deposition		 Issued 1/17/02 Patent No. WO 02/04328 A1
17. Multi-Step Drug Dosage Forms Issued 7/26/01 Patent No. WO 01/52815 A1
18. Medication Dispenser for Dispensing Flat
Dosage Forms		 Issued 5/28/02 Patent No. US 6394306
19. Improved Thyroid Hormone Formulations Issued 1/17/02   Patent No. WO 02/03914 A2
20. Substrates for Powder deposition Containing
Conductive Domains		 Issued 1/18/05 Patent No. US 6844048
21. Medication Dry Powder Inhaler Dispensing
Device		 Issued 6/22/04 Patent No. US 6752148
LIST OF PUBLICATIONS
Chapters
1. Clarification and Filtration - S. Chrai, in Theory and Practice of Industrial Pharmacy, Lachman, Lieberman & Kanig, Editors. Lea & Febiger, 1986, Philadelphia. 
2. Accudep Technology for Oral Modified Drug Release - S. Chrai, D. Friend, G. Kupperblatt, R. Murari, T. Francis, J. Butler, A. Raoof and B. McKenna. Submitted  
Articles
1. Guest Editorial - A Historical Perspective on Sterile Filtration - Suggy S. Chrai. Pharmaceutical Technology, 19, No. 4, 12 (1995) 
2. Glass Vial Container Closure Integrity Testing - An Overview - Suggy S. Chrai, Gayle Heffernan, and Ted Myers. Pharmaceutical Technology, 18, No.10, 162 (1994). 
3. Validation Considerations for Selecting Filter Housings - Suggy S. Chrai.  Pharmaceutical Technology, 13, No. 9, 84 (1989).
4. Integrity Tests for Filter Systems - Suggy S. Chrai.  Pharmaceutical Technology, 12, No. 10, 62 (1988).
5. Limitations in the Use of the HIAC for Product Particle Counting - Suggy Chrai, M. Sokol, R. Clayton, R. Raskin, C. Willis, and L. Mastrandrea.  J. Pharmaceutical Technology & Sciences 41, 209 (1987).
6. Cycle Development Criteria for Removal of Endotoxin by Dilution From Glassware - David Berman, Ted Kasica, Ted Myers, and Suggy Chrai.  J. Pharmaceutical Technology & Sciences, 41, 158 (1987).
7. Effect of Terminal Sterilization on Packaging Components - Suggy S. Chrai.  Proceedings of Society of Manufacturing Engineers - Pharmaceutical Packaging Technology Seminar, October 1987.
8. Approaches to Cycle Development of Clean-In-Place Processes - Ted Myers, Ted Kasica, and Suggy Chrai.  J. of Parenteral Science and Technology, 41, 8 (1987).
9. Factors Involved in Cycle Development of a Steam-in-Place System - David Berman, Ted Myers, and Suggy Chrai.  J. of Parenteral Science and Technology, 40, 119 (1986).
10. Decontamination Agents; Prepared by PDA Task Force; Suggy Chrai, Chairman; Paul Mason, Leonard Mastrandrea, Ted Myers, Deirdre O'Connor, Jim Pallermo, Simon Rusmin, Christopher Smally, Linda Tilton, and J. Wilson.  J. Parenteral Science and Technology, 40, 104 (1986).
11. Validation of Filtration Processes Used for Sterilization of Liquids - E. Hardwidge, S. Chrai, F. Dawson, C. Rodowitz, T. Meltzer, and W. Zeronsa.  J. Parenteral Science and Technology, 38,  (1984)
12. Design Consideration for Validation of Water for Injection System - R. Keifer, F. Carleton, D. Conrad, R. Myers, and S. Chrai.  Technical Information No. 4, Parenteral Drug Association.
13. Microbiological Evaluation of Filters For Sterilizing Liquids - Sukhbir S. Chrai  et. al. HIMA Document No. 3 Vol. 4, April 1982.
14. Steam In-Place Sterilization of Cartridge Filters in Line with a Receiving Tank- Ted Myers and Suggy Chrai.  J. Parenteral Science and Technology, 36, 108 (1982).
15. Functionality and Economics of Tangential Flow Microfiltration - R. C. Lukazewicz, A. Kurin, D. Hauk, S. Chrai.  J. Parenteral Science and Technology, 35, 231 (1981).
16. The Influence of Pre-Sterilization Conditioning on Ethylene Oxide Bioindicator Performance - T. Myers, M. Lipstein, K. Troppoli, and S. Chrai.  J. Parenteral Science and Technology, 35, 98 (1981).
17. Design Consideration for Development of Steam In-Place Sterilization Processes - T. Myers and S. Chrai.  J. Parenteral Science and Technology, 35, 8 (1981).
18. Depyrogenation of a Parenteral Solution by Ultrafiltration - D. Abramson, L. D. Butler, and S. Chrai.  J. Parenteral Science and Technology, 35, 3 (1981).
19. Basic Principles and Applications of Bioindicators - S. S. Chrai and T. Myers.  Journal of Parenteral Drug Assoc., 34, 234 (1980).
20. Gentamicin Sulfate Injection Repackaging in Syringes - S. S. Chrai and T. J. Ambrosio.  Am.  J. Hospital Pharmacy, 34, 234 (1980).
21. Stability of Gentamicin Sulfate Admixture - S. S. Chrai, K.P. Phelan, E. R. Speicher, and J. A. Waitz.  Am. J. Hospital Pharmacy, 34, 195 (1977).
22. Interaction of Label Adhesive with Benzalkonium Chloride Preserved Ophthalmic Solutions Packaged in Plastic Bottles - S. S. Chrai, S. Gupta, and K. Brychta.  Bulletin of Parenteral Drug Association, 31, 195 (1977).
23. Sterile, Micronized Hydrocortisone - A Simple Method of Preparation - S. S. Chrai and E. I. Stupak.  Bulletin of Parenteral Drug Association, 30, 100 (1976).
24. Binding of Sulfisoxazole to Protein Fractions of Tears - S. S. Chrai and J. R. Robinson.  J. Pharmaceutical Sciences, 65, 437 (1976).
25. Some Ocular Pharmacokinetics Aspects of Pilocarpine Nitrate in Albino Rabbits - S. S. Chrai and J. R. Robinson.  Amer. J. Ophthalmology, 77, 735 (1974).
26. Ocular Evaluation of Methylcellulose Vehicle in Albino Rabbit - S. S. Chrai and J. R. Robinson. J. Pharmaceutical Sciences, 63, 1218 (1974).
27. Drop Size and Initial Dosing Frequency Problems of Topically Applied Ophthalmic Drug - S. S. Chrai, M. C. Makoid, S. P. Erikson, and J. R. Robinson.  J. Pharmaceutical Sciences, 63, 333 (1974).
28. Competitive Inhibition of Drug Protein Interaction in Eye Fluids and Tissues - T. J. Mikkelson, S. S. Chrai, and J. R. Robinson.  J. Pharmaceutical Sciences, 62, 1942 (1973).
29. Altered Bioavailability of Drugs in the Eye Due to Drug Protein Interaction - T. J. Mikkelson, S. S. Chrai, and J. R. Robinson.  J. Pharmaceutical Sciences, 62, 1648 (1973).
30. Lacrimal and Instilled Fluid Dynamics in Rabbit Eyes - S. S. Chrai, T. F. Patton, A. Mehta, and J. R. Robinson.  J. Pharmaceutical Sciences, 62, 1112 (1973).
31. The Model Stream Approach: Defining the Worst - Case Conditions, T.E. Stone, Vinay Goel, Jackie Leszcak and S. S. Chrai.   Pharmaceutical Technology, 20 No 5. 34, (1996).
32. Electrostatic Deposition of Dry Powders, S. Chrai, B. Singh et. al.  Pharmaceutical Technology, 22 No 4, 106, (1998).
33. Accudep Technology: On-Line Process Monitoring, S. Chrai, R. Murari, and R. Roach. Accepted for Publication - Innovations of Pharmaceutical Technology UK.
34. Accudep: A Novel Technique in Dosage Form Development, D. R. Friend and S. S. Chrai. Submitted for publication in the Controlled Release Society Newsletter.
35. Mathematical Modeling of a Novel Controlled – Release Dosage Form, David R. Friend, Gregory E.  Parry, T. Francis, Gerald Slack, Gary Kupperblatt, and Suggy Chrai. Drug Delivery Technology, 1, No. 1, 36, (2001).
36. Liposome, Part1: Manufacturing Issues, Suggy S. Chrai, R. Murari and Imran Ahmad. BioPharm, 14, No. 11, 10, 2001
37. Drug Delivery Liposomes, Part II: Drug Delivery Systems, Suggy S. Chrai, R. Murari and Imran Ahmad. BioPharm, 15, No. 1, 40-43, 2002
38. Liposome, Part I: Manufacturing Issues, Suggy S. Chrai, R. Murari and Imran Ahmad. BioPharm,  Europe Special Issue pp. 33-37, September 2002
39. Drug Delivery Liposomes, Part II: Drug Delivery Systems, Suggy S. Chrai, R. Murari and Imran Ahmad. BioPharm. Europe  15, No. 2,  53-56, 2003
40. Liposome (a Review), Part One: Manufacturing Issues, Suggy S. Chrai, R. Murari and Imran Ahmad. Pharmaceutical. Technology Europe, 14, No. 11, 10, 2001
41. Drug Delivery Liposomes, Part II: Drug Delivery Systems, Suggy S. Chrai, R. Murari and Imran Ahmad. Pharmaceutical. Technology Europe 16, No. 2,  53-56, 2003
42. Liposome (a Review), Part One: Manufacturing Issues, Suggy S. Chrai, R. Murari and Imran Ahmad. Pharmaceutical. Technology 25, No. 11, 10, 2001
43. Drug Delivery Liposomes, Part II: Drug Delivery Systems, Suggy S. Chrai, R. Murari and Imran Ahmad Pharmaceutical. Technology  26, No. 2,  53-56, 2002
44. Outsourcing of Quality Control in Pharmaceutical Industry, Suggy S. Chrai, and Marianne Scheffler. American Pharmaceutical Outsourcing  4, No. 2,  53-56, 2003
45. Pharmaceutical Outsourcing, Suggy S. Chrai, American Pharmaceutical Outsourcing  3, No. 3,  16-19, 2002
46. Electronic Records & Electronic Signatures, Suggy S. Chrai, Contract Pharma  3,  46-55, November/December 2002
47. Consent Decrees – Effect on Consumers, Companies, and Investors, Suggy S. Chrai, and Michele Burd. Pharmaceutical. Technology  28, No. 3,  168-182, 2004
48. Outsourcing of Clinical Supplies Part I, Suggy ChraiContract Pharma 5, 48-53, May 2004
49. Outsourcing of Clinical Supplies Part II, Suggy ChraiContract Pharma 5, 104-111, June 2004
50. After the Consent Decree – An Uphill Battle for Affected Companies, Suggy Chrai and Michelle Burd, International BioPharm 17,   26-36, June 2004